Breaking News, Financial News

Financial Report: Abbott

Abbott

1Q Revenues: $5.3 billion (15.5%)

1Q Earnings: $697.5 million (-19%)

Comments: Worldwide pharmaceutical sales were $3.4 billion, up 16.6%. Humira grew to $289 million in sales, up $32.4. Earnings in the quarter excludes after-tax charges of $57 million for acquisition integration, $75 million related to fair value adjustments of Abbott’s investment in Boston Scientific, and $55 million for cost reduction initiatives.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters